TLR9 and metabolic dysfunction-associated steatohepatitis: The wild type mice on a 12-week HFD developed hepatosteatosis, balloon cells, and inflammation with elevated ALT, while both the Lysm-Cre Tlr9fl/fl mice and TLR9 KO mice exhibited NASH component histology that was significantly less severe.